• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY PROMUS ELEMENT¿ PLUS; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY PROMUS ELEMENT¿ PLUS; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number H7493911416350
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Congestive Heart Failure (1783); Death (1802); Dyspnea (1816); High Blood Pressure/ Hypertension (1908); Low Blood Pressure/ Hypotension (1914); Diaphoresis (2452)
Event Date 07/17/2016
Event Type  Death  
Manufacturer Narrative
Device is a combination product.Device evaluated by mfr: it is indicated that the device will not be returned for evaluation.A review of the batch history, historical trending, and similar complaint trending review for the product family will be conducted.If there is any further relevant information from that review, a supplemental medwatch will be filed.(b)(4).
 
Event Description
(b)(6) clinical study.It was reported that congestive heart failure was experienced and the patient died.In (b)(6) 2012, the patient was diagnosed with unstable angina and was referred for cardiac catheterization.Subsequently, index procedure was performed.The target lesion was a de novo lesion located in the mid left anterior descending (lad) with 95 % stenosis and was 14 mm long with a reference vessel diameter of 3.5 mm.The target lesion was treated with pre-dilatation and placement of a 3.50 x 16 mm promus element¿ plus stent with 0 % residual stenosis.Fourteen days after, the patient was discharged on aspirin and prasugrel.In (b)(6) 2016, the patient was diagnosed with congestive heart failure and was hospitalized on the same day.Medication was given in response to the event.Nine days after, the event was considered as resolved and was discharged on aspirin and prasugrel.In (b)(6) 2016, the patient was presented to emergency department (ed) with increasing shortness of breath, swelling of leg, slight decrease in urine output and was diagnosed with decompensated heart failure.Patient's b-type natriuretic peptide (bnp) was noted to be elevated, chest x-ray revealed some vascular congestion and electrocardiography (ecg) revealed ventricular paced rhythm with frequent atrial and ventricular (av) dual-paced complexes, an abnormal ecg.Upon cardiac consultation in ed, dobutamine infusion at low dose was started and intravenous (iv) lasix was continued and patient was hospitalized on the same day.Following therapeutic strategies after few days, there was a partial improvement in patient's condition but during the later days, the patient stopped responding to the therapy and in spite of iv infusion therapy, patient's urine output was very poor with creatinine level (elevated from 2.43 to 4.80 mg/dl).There after, the patient developed significant hypotension and felt uncomfortable due to developing of cold skin, clamminess and diaphoresis.Subsequently, lasix drip was discontinued.Eventually, seven days after, the patient automatic implantable cardioverter-defibrillator (aicd) was turned off and the patient was noted to be in end stage heart failure with a very poor prognosis.Two days after, hospice care was initiated for symptoms control.During the hospice care, the patient's upper elbow and lower elbow turned into ashen color with respiratory rate @ 1-2 breaths per minute.On the same day, the patient expired due to congestive heart failure.Per death certificate, primary cause of death was acute systolic congestive heart failure and underlying causes were chronic kidney disease and hypertension.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS ELEMENT¿ PLUS
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
Manufacturer Contact
sonali arangil
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key6421352
MDR Text Key70480862
Report Number2134265-2017-02380
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier08714729808015
UDI-Public(01)08714729808015(17)20130503(10)15303434
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P110010
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 03/06/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/21/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/03/2013
Device Model NumberH7493911416350
Device Catalogue Number39114-1635
Device Lot Number15303434
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/06/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/11/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death; Hospitalization;
Patient Age83 YR
-
-